Article
Newly attenuated Mycobacterium bovis mutants as vaccines against bovine tuberculosis, particularly for possums.
Veterinary microbiology - 5 Jul 2011
Collins D M, Buddle B M, Kawakami R P, Hotter G, Mildenhall N, Mouat P, Murney R, Ataera H, Price-Carter M, Bruere P, Wards B J, de Lisle G W
Abstract excerpt
Bovine tuberculosis costs New Zealand more than $80 million per year, mostly because extensive areas of the country are occupied by brushtail possums infected with Mycobacterium bovis. AgResearch has a major programme to produce new live tuberculosis vaccines that can be delivered to possums. Primary work involved development of molecular biological methods to enable genetic manipulation of M. bovis, including...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.